nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—DRD2—Gilles de la Tourette syndrome	0.474	0.564	CbGaD
Minaprine—HTR2A—Gilles de la Tourette syndrome	0.366	0.436	CbGaD
Minaprine—MAOA—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.00733	0.0586	CbGpPWpGaD
Minaprine—ACHE—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.00617	0.0493	CbGpPWpGaD
Minaprine—MAOA—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.00581	0.0465	CbGpPWpGaD
Minaprine—DRD1—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00523	0.0418	CbGpPWpGaD
Minaprine—DRD1—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00508	0.0406	CbGpPWpGaD
Minaprine—DRD1—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.00473	0.0378	CbGpPWpGaD
Minaprine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00407	0.117	CbGeAlD
Minaprine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00395	0.0316	CbGpPWpGaD
Minaprine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00384	0.0306	CbGpPWpGaD
Minaprine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00355	0.0284	CbGpPWpGaD
Minaprine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00335	0.0267	CbGpPWpGaD
Minaprine—ACHE—midbrain—Gilles de la Tourette syndrome	0.00175	0.0504	CbGeAlD
Minaprine—HTR2B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00174	0.0139	CbGpPWpGaD
Minaprine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00161	0.0462	CbGeAlD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00144	0.0115	CbGpPWpGaD
Minaprine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00141	0.0112	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00136	0.0108	CbGpPWpGaD
Minaprine—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00135	0.0108	CbGpPWpGaD
Minaprine—DRD1—nervous system—Gilles de la Tourette syndrome	0.00132	0.038	CbGeAlD
Minaprine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00127	0.0366	CbGeAlD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00125	0.01	CbGpPWpGaD
Minaprine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00125	0.0359	CbGeAlD
Minaprine—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00123	0.0098	CbGpPWpGaD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00122	0.00972	CbGpPWpGaD
Minaprine—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00119	0.00951	CbGpPWpGaD
Minaprine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00118	0.034	CbGeAlD
Minaprine—ACHE—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00117	0.00936	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00116	0.00927	CbGpPWpGaD
Minaprine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00116	0.00926	CbGpPWpGaD
Minaprine—DRD1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00116	0.00924	CbGpPWpGaD
Minaprine—DRD1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00115	0.00919	CbGpPWpGaD
Minaprine—DRD1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00112	0.00897	CbGpPWpGaD
Minaprine—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00111	0.00886	CbGpPWpGaD
Minaprine—ACHE—brain—Gilles de la Tourette syndrome	0.0011	0.0317	CbGeAlD
Minaprine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00107	0.00856	CbGpPWpGaD
Minaprine—DRD1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00105	0.00836	CbGpPWpGaD
Minaprine—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00103	0.00824	CbGpPWpGaD
Minaprine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00103	0.0295	CbGeAlD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00102	0.00818	CbGpPWpGaD
Minaprine—DRD1—brain—Gilles de la Tourette syndrome	0.00101	0.029	CbGeAlD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00101	0.00805	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.001	0.00801	CbGpPWpGaD
Minaprine—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.001	0.008	CbGpPWpGaD
Minaprine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000989	0.0079	CbGpPWpGaD
Minaprine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000988	0.0284	CbGeAlD
Minaprine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000973	0.028	CbGeAlD
Minaprine—DRD1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000972	0.00777	CbGpPWpGaD
Minaprine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000969	0.0279	CbGeAlD
Minaprine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000964	0.0277	CbGeAlD
Minaprine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000961	0.00767	CbGpPWpGaD
Minaprine—MAOA—midbrain—Gilles de la Tourette syndrome	0.00096	0.0276	CbGeAlD
Minaprine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000949	0.0273	CbGeAlD
Minaprine—DRD1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000944	0.00754	CbGpPWpGaD
Minaprine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000936	0.0269	CbGeAlD
Minaprine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.000935	0.00747	CbGpPWpGaD
Minaprine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000933	0.0268	CbGeAlD
Minaprine—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000932	0.00745	CbGpPWpGaD
Minaprine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000928	0.0267	CbGeAlD
Minaprine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000895	0.00715	CbGpPWpGaD
Minaprine—DRD1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000879	0.00702	CbGpPWpGaD
Minaprine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000873	0.00698	CbGpPWpGaD
Minaprine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000869	0.00694	CbGpPWpGaD
Minaprine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000859	0.00686	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000855	0.00683	CbGpPWpGaD
Minaprine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000848	0.00677	CbGpPWpGaD
Minaprine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000834	0.00666	CbGpPWpGaD
Minaprine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000832	0.00664	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00083	0.00663	CbGpPWpGaD
Minaprine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000807	0.00645	CbGpPWpGaD
Minaprine—MAOA—nervous system—Gilles de la Tourette syndrome	0.000789	0.0227	CbGeAlD
Minaprine—HTR2C—brain—Gilles de la Tourette syndrome	0.000784	0.0226	CbGeAlD
Minaprine—DRD2—nervous system—Gilles de la Tourette syndrome	0.00078	0.0224	CbGeAlD
Minaprine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000777	0.00621	CbGpPWpGaD
Minaprine—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000777	0.00621	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000773	0.00617	CbGpPWpGaD
Minaprine—MAOA—central nervous system—Gilles de la Tourette syndrome	0.00076	0.0218	CbGeAlD
Minaprine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000752	0.00601	CbGpPWpGaD
Minaprine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000751	0.0216	CbGeAlD
Minaprine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000743	0.0214	CbGeAlD
Minaprine—CHRM1—brain—Gilles de la Tourette syndrome	0.000741	0.0213	CbGeAlD
Minaprine—HTR2B—brain—Gilles de la Tourette syndrome	0.000737	0.0212	CbGeAlD
Minaprine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000734	0.00586	CbGpPWpGaD
Minaprine—DRD1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000733	0.00585	CbGpPWpGaD
Minaprine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000722	0.00577	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000718	0.00574	CbGpPWpGaD
Minaprine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000713	0.00569	CbGpPWpGaD
Minaprine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000701	0.0056	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000697	0.00557	CbGpPWpGaD
Minaprine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000653	0.00522	CbGpPWpGaD
Minaprine—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000653	0.00522	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00065	0.00519	CbGpPWpGaD
Minaprine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000627	0.00501	CbGpPWpGaD
Minaprine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000626	0.018	CbGeAlD
Minaprine—DRD1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000616	0.00492	CbGpPWpGaD
Minaprine—MAOA—brain—Gilles de la Tourette syndrome	0.000603	0.0173	CbGeAlD
Minaprine—DRD2—brain—Gilles de la Tourette syndrome	0.000596	0.0172	CbGeAlD
Minaprine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000553	0.00442	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000541	0.00432	CbGpPWpGaD
Minaprine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000527	0.00421	CbGpPWpGaD
Minaprine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000515	0.0148	CbGeAlD
Minaprine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000496	0.0142	CbGeAlD
Minaprine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000469	0.0135	CbGeAlD
Minaprine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000465	0.00371	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000455	0.00364	CbGpPWpGaD
Minaprine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000451	0.013	CbGeAlD
Minaprine—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.0004	0.00319	CbGpPWpGaD
Minaprine—HTR2A—brain—Gilles de la Tourette syndrome	0.000393	0.0113	CbGeAlD
Minaprine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000382	0.00305	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000371	0.00296	CbGpPWpGaD
Minaprine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000358	0.0103	CbGeAlD
Minaprine—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000336	0.00269	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000327	0.00261	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000304	0.00243	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000273	0.00218	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00027	0.00216	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000265	0.00211	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000261	0.00208	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000255	0.00204	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000246	0.00197	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000237	0.00189	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00023	0.00184	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000223	0.00178	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000217	0.00173	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000214	0.00171	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000214	0.00171	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000207	0.00166	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000206	0.00164	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000203	0.00162	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000202	0.00161	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000201	0.00161	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.0002	0.0016	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000197	0.00157	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000195	0.00156	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000195	0.00156	CbGpPWpGaD
Minaprine—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000194	0.00155	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000191	0.00153	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000191	0.00153	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000186	0.00148	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000185	0.00148	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000183	0.00147	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000182	0.00145	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000182	0.00145	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000176	0.00141	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000173	0.00139	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000173	0.00138	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000173	0.00138	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000169	0.00135	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000166	0.00132	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000165	0.00132	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000164	0.00131	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000164	0.00131	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000161	0.00129	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00016	0.00128	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000159	0.00127	CbGpPWpGaD
Minaprine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000156	0.00125	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000154	0.00123	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00015	0.0012	CbGpPWpGaD
Minaprine—ACHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00015	0.0012	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00015	0.0012	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00015	0.0012	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000149	0.00119	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000148	0.00118	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000146	0.00116	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000144	0.00115	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000142	0.00113	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000141	0.00113	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000141	0.00113	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000141	0.00113	CbGpPWpGaD
Minaprine—MAOA—Metabolism—HDC—Gilles de la Tourette syndrome	0.000141	0.00113	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00014	0.00112	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00014	0.00112	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00014	0.00112	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000138	0.0011	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000137	0.0011	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00108	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000132	0.00105	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000128	0.00103	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000128	0.00103	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000128	0.00102	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000125	0.000995	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000121	0.000968	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000121	0.000966	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000121	0.000966	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000121	0.000966	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000113	0.0009	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00011	0.000878	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000108	0.000864	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000108	0.00086	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000107	0.000853	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000107	0.000853	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000105	0.000839	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000835	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000104	0.000835	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000828	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.78e-05	0.000782	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.78e-05	0.000781	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.73e-05	0.000777	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.22e-05	0.000737	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.14e-05	0.000731	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.95e-05	0.000715	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.73e-05	0.000697	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.47e-05	0.000677	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.23e-05	0.000657	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.99e-05	0.000638	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.92e-05	0.000633	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.89e-05	0.00063	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.89e-05	0.00063	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.69e-05	0.000615	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.47e-05	0.000597	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.44e-05	0.000595	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.25e-05	0.00058	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.17e-05	0.000573	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.04e-05	0.000562	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.96e-05	0.000556	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.83e-05	0.000546	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.82e-05	0.000544	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.76e-05	0.00054	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.39e-05	0.000511	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.37e-05	0.000509	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.21e-05	0.000496	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.21e-05	0.000496	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	6.15e-05	0.000491	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.11e-05	0.000488	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.08e-05	0.000486	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.03e-05	0.000482	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.93e-05	0.000474	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.9e-05	0.000472	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.78e-05	0.000462	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.64e-05	0.000451	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.55e-05	0.000444	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.53e-05	0.000442	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.53e-05	0.000442	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.52e-05	0.000441	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.5e-05	0.000439	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.48e-05	0.000438	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.39e-05	0.000431	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.36e-05	0.000428	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.21e-05	0.000416	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.02e-05	0.000401	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000401	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.99e-05	0.000399	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.73e-05	0.000378	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.68e-05	0.000374	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000363	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.46e-05	0.000356	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.41e-05	0.000353	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.29e-05	0.000342	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000338	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.05e-05	0.000324	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.99e-05	0.000319	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000314	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000308	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.78e-05	0.000302	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.67e-05	0.000293	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.57e-05	0.000286	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.5e-05	0.000279	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.42e-05	0.000273	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.33e-05	0.000266	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.28e-05	0.000262	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.26e-05	0.000261	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.24e-05	0.000258	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.18e-05	0.000254	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.17e-05	0.000253	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000237	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.96e-05	0.000237	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.95e-05	0.000236	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.8e-05	0.000223	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.39e-05	0.000191	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000169	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000165	CbGpPWpGaD
